Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

v3.24.1.u1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive (Loss) Income
Total
BALANCE at Dec. 31, 2022 $ 32 $ 1,874,792 $ (1,308,954) $ (38,368) $ 527,502
BALANCE (in shares) at Dec. 31, 2022 318,133,434        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of Common Stock options   597     597
Exercise of Common Stock options (in shares) 495,876        
Vesting of restricted Common Stock (in shares) 25,375        
Vesting of restricted stock units (in shares) 1,808,422        
Repurchase of shares for employee tax withholdings   (99)     (99)
Repurchase of shares for employee tax withholdings (in shares) (61,718)        
Stock-based compensation expense   8,474     8,474
Net loss     (52,642)   (52,642)
Other comprehensive income (loss)       1,738 1,738
BALANCE at Mar. 31, 2023 $ 32 1,883,764 (1,361,596) (36,630) 485,570
BALANCE (in shares) at Mar. 31, 2023 320,401,389        
BALANCE at Dec. 31, 2023 $ 33 1,908,504 (1,632,225) (34,660) $ 241,652
BALANCE (in shares) at Dec. 31, 2023 325,271,670        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of Common Stock options (in shares)         0
Vesting of restricted Common Stock (in shares) 5,749        
Vesting of restricted stock units (in shares) 4,963,667        
Repurchase of shares for employee tax withholdings   (328)     $ (328)
Repurchase of shares for employee tax withholdings (in shares) (535,893)        
Issuance of common stock related to share-based liability awards   1,997     1,997
Stock-based compensation expense   7,333     7,333
Net loss     (52,098)   (52,098)
Other comprehensive income (loss)       (1,218) (1,218)
BALANCE at Mar. 31, 2024 $ 33 $ 1,917,506 $ (1,684,323) $ (35,878) $ 197,338
BALANCE (in shares) at Mar. 31, 2024 329,705,193